Tesofensine — Research Overview

A triple monoamine reuptake inhibitor originally developed for Parkinson's disease, studied for its effects on appetite suppression through dopamine, norepinephrine, and serotonin reuptake inhibition. Research has shown meaningful weight-loss effects in clinical trials.

Back to Peptide Encyclopedia